Comparison of the efficacy, safety, and tolerability of the FDC of telmisartan + bisoprolol with telmisartan + metoprolol succinate ER combination therapy for stage 1 and stage 2 hypertension: A double-blind, multicentric, phase-III clinical study.
Gurpreet S WanderBhim RamSatyendra Kumar SonkarC N ManjunathPadmanabh KamathL SreenivasamurthyR BalamuruganSsvv Narasinga RaoDebabrata RoyPrajapati Vipulkumar BachubhaiManjula SKrishna Kumar MPublished in: Indian heart journal (2024)
Clinical Trials Registry of India (CTRI) TRIAL REGISTRATION NO: CTRI/2021/11/037,926 PROTOCOL NO: MLBTL/05/2021 PROTOCOL URL: https://ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=62069&EncHid=&userName=bisoprolol.